Charcot Marie Tooth Disease - Epidemiology and Market Forecast-2028

Albany, NY -- (SBWire) -- 04/11/2019 --Charcot Marie Tooth Disease - Epidemiology and Market Forecast-2028

Charcot Marie Tooth Disease is the most commonly inherited peripheral nerve disorder affecting about 1 in 2500 people.

1. Charcot Marie Tooth affects an estimated 150,000 people in the United States. It occurs in populations worldwide with a prevalence of about 1 in 3300 individuals.
2. Charcot Marie Tooth total diagnosed prevalent population in 7 major markets will increase from 3,878 cases in 2028.
3. Among the European countries, France had the highest diagnosed prevalent population of Charcot Marie Tooth with 272 cases.

DelveInsight launched a new report on Charcot Marie Tooth - Market Insights, Epidemiology and Market Forecast-2028

Key benefits

1. Charcot Marie Tooth market report covers a descriptive overview and comprehensive insight of the Charcot Marie Tooth epidemiology and Charcot Marie Tooth market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. Charcot Marie Tooth market report provides insights on the current and emerging therapies.
3. Charcot Marie Tooth market report provides a global historical and forecasted market covering drug outreach in 7 MM.
4. Charcot Marie Tooth market report provides an edge that will help in developing business strategies, by understanding trends shaping and driving the Charcot Marie Tooth market.

"The inheritance pattern varies with the type of Charcot-Marie-Tooth disease. CMT1, most cases of CMT2, and intermediate forms are inherited in an autosomal dominant pattern."

Charcot Marie Tooth therapeutic market is expected to change for the forecast period of 2019-2028 in the seven major markets. Charcot Marie Tooth highest market size is of the United States, which accounts for approximately 47% of the total market. On the contrary, Spain accounted for the least market share (8.62%) among the 7MM countries.

Charcot Marie Tooth market size is expected to experience steady growth throughout the study period [2017-2028], owing to the lack of any significant curative treatment options. However, the emerging therapies targeted to reduce the symptoms of Charcot Marie Tooth, are expected to fuel the growth of the market. Overall, the increasing prevalence, awareness of the disease and emerging pipeline therapies will propel the Charcot Marie Tooth market size forward during the forecasted period of 2019-2028.

Charcot Marie Tooth market dynamics is anticipated to undergo change during the forecast period owing to the expected launch of potential therapies, which may increase market size in the coming years, assisted by an increase in Charcot Marie Tooth diagnosed prevalent population. There is no cure for Charcot-Marie-Tooth disease (CMT), but there as some therapies and other management methods which are available to help reduce the symptoms and enable to live as independently as possible. These therapies include physiotherapy, occupational therapy; Orthoses and walking aids, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs, such as ibuprofen) for controlling pain, surgery, Osteotomy, Arthrodesis, and Plantar fascia release, etc.

The key players are:
1. Pharnext
2. Acceleron
3. MedDay Pharmaceuticals
And many others

Drugs covered

1. PXT3003
2. ACE-083
3. MD1003
And many others

Table of contents
1. Report Introduction
2. Charcot Marie Tooth Market Overview at a Glance
3. Charcot Marie Tooth Disease Background and Overview
4. Charcot Marie Tooth Epidemiology and Patient Population
5. Epidemiology of Charcot Marie Tooth by Countries (2017-2028)
5.1. United States- Epidemiology (2017-2028)
5.2. EU-5 - Epidemiology (2017-2028)
5.3. Germany-Epidemiology (2017-2028)
5.4. France-Epidemiology (2017-2028)
5.5. Italy-Epidemiology (2017-2028)
5.6. Spain-Epidemiology (2017-2028)
5.7. United Kingdom-Epidemiology (2017-2028)
5.8. Japan-Epidemiology (2017-2028)
6. Charcot Marie Tooth Treatments & Medical Practices
7. Charcot Marie Tooth Emerging Therapies
7.1. Key Cross Competition
7.2. PXT3003: Pharnext
7.3. ACE-083: Acceleron
7.4. MD1003: MedDay Pharmaceuticals
8. Charcot Marie Tooth Market Size
9. Charcot Marie Tooth 7MM Country-Wise Market Analysis
9.1. United States Market Size
9.2. Germany Market Size
9.3. France Market Size
9.4. Italy Market Size
9.5. Spain Market Size
9.6. United Kingdom Market Size
9.7. Japan Market Size
10. Market Drivers
11. Market Barriers
12. Report Methodology
13. DelveInsight Capabilities
14. Disclaimer
15. About DelveInsight

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Contact us:
Shruti Thakur
info@delveinsight.com
+919650213330
SOURCE DelveInsight